What is the minimum effective dose of trazodone required for disease-modifying effects in dementia?
INVESTIGATING
The study found trazodone prescribed at doses less than half that predicted to be disease-modifying, but the actual therapeutic threshold remains undefined. This dosing uncertainty prevents proper evaluation of trazodone's neuroprotective potential in clinical settings.
Gap type: open_question
Source paper: Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data. (2022, International journal of geriatric psychiatry, PMID:35921312)
Landscape Summary:
What is the minimum effective dose of trazodone required for disease-modifying effects in dementia? is a 0.87 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: investigating.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
What is the minimum effective dose of trazodone required for disease-modifying effects in dementia? — INVOKE-2 (completed)
📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
2
Debates
0.82
Avg Quality
30%
Resolution
0
Mechanistic Families
Gap Resolution Progress30%
Hypothesis Score Distribution
🏆 Competing Hypotheses (Ranked by Score)
No hypotheses linked to this gap yet.
🌊 Knowledge Graph Connections
No knowledge graph edges recorded
🕑 Activity Feed
🎭What is the minimum effective dose of trazodone required forq=1.002026-04-26T16:04
🎭What is the minimum effective dose of trazodone required forq=0.642026-04-25T17:45
✏update on knowledge_gapby None2026-04-22T19:29
✏update on knowledge_gapby None2026-04-22T14:14
💬 Discussion
No discussions yet. Be the first to comment.
📋 Investigation Sub-Tasks
Create sub-tasks to investigate specific aspects of this gap:
Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions